This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 88/10/1004    most recent hh1001.090878v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pasumarthi, K. B. S. Articles by Field, L. J. Search for Related Content PubMed PubMed Citation Articles by Pasumarthi, K. B. S. Articles by Field, L. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Stem Cells Related Collections Apoptosis Cell signalling/signal transduction Myogenesis Cardiac development Gene therapy

(Circulation Research. 2001;88:1004.)
© 2001 American Heart Association, Inc.

Molecular Medicine

Coexpression of Mutant p53 and p193 Renders Embryonic Stem Cell–Derived Cardiomyocytes Responsive to the Growth-Promoting Activities of Adenoviral E1A

Kishore B. S. Pasumarthi, Shih-Chong Tsai, Loren J. Field

From the Wells Center for Pediatric Research and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Ind. Present address of S.-C.T. is Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.

Correspondence to Dr Loren J. Field, Herman B Wells Center for Pediatric Research, James Whitcomb Riley Hospital for Children, 702 Barnhill Dr, Room 2600, Indianapolis, IN 46202-5225. E-mail ljfield{at}iupui.edu

Abstract—Expression of adenoviral E1A in cardiomyocytes results in the activation of DNA synthesis followed by apoptosis. In contrast, expression of simian virus 40 large T antigen induces sustained cardiomyocyte proliferation. Previous studies have shown that T antigen binds to 2 proapoptotic proteins in cardiomyocytes, namely the p53 tumor suppressor and p193 (a new member of the BH3-only proapoptosis subfamily). Structure-function analyses identified a p193 C-terminal truncation mutant that encodes prosurvival activity. This mutant was used to test the role of p193 in E1A-induced cardiomyocyte apoptosis. E1A induced apoptosis in cardiomyocytes derived from differentiating embryonic stem cells. Expression of the prosurvival p193 mutant alone or a mutant p53 alone did not block E1A-induced apoptosis. In contrast, combinatorial expression of mutant p193 and mutant p53 blocked E1A-induced apoptosis, resulting in a proliferative response indistinguishable from that seen with T antigen. These results confirm the hypothesis that there are 2 proapoptotic pathways, encoded by p53 and p193, respectively, which restrict cardiomyocyte cell cycle activity in differentiating embryonic stem cell cultures. Furthermore, these results explain in molecular terms the phenotypic differences of E1A versus T-antigen gene transfer in cardiomyocytes.

Key Words: cardiomyocyte proliferation • cardiac myocyte apoptosis • heart regeneration

This article has been cited by other articles:

				R J Hassink, H Nakajima, H O Nakajima, P A Doevendans, and L J Field Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarction Heart, July 15, 2009; 95(14): 1159 - 1164. [Abstract] [Full Text] [PDF]

				H. Nakajima, H. O. Nakajima, K. Dembowsky, K. B.S. Pasumarthi, and L. J. Field Cardiomyocyte Cell Cycle Activation Ameliorates Fibrosis in the Atrium Circ. Res., January 6, 2006; 98(1): 141 - 148. [Abstract] [Full Text] [PDF]

				M. Rubart and D. P. Zipes Genes and Cardiac Repolarization: The Challenge Ahead Circulation, August 30, 2005; 112(9): 1242 - 1244. [Full Text] [PDF]

				K. M. Regula and L. A. Kirshenbaum Breaking Down Cell-Cycle Barriers in the Adult Heart Circ. Res., June 25, 2004; 94(12): 1524 - 1526. [Full Text] [PDF]

				H. Nakajima, H. O. Nakajima, S.-C. Tsai, and L. J. Field Expression of Mutant p193 and p53 Permits Cardiomyocyte Cell Cycle Reentry After Myocardial Infarction in Transgenic Mice Circ. Res., June 25, 2004; 94(12): 1606 - 1614. [Abstract] [Full Text] [PDF]

				J. D. Dowell, M. Rubart, K. B.S. Pasumarthi, M. H. Soonpaa, and L. J. Field Myocyte and myogenic stem cell transplantation in the heart Cardiovasc Res, May 1, 2003; 58(2): 336 - 350. [Abstract] [Full Text] [PDF]

				C. Perez-Terzic, A. Behfar, A. Mery, J. M.A. van Deursen, A. Terzic, and M. Puceat Structural Adaptation of the Nuclear Pore Complex in Stem Cell-Derived Cardiomyocytes Circ. Res., March 7, 2003; 92(4): 444 - 452. [Abstract] [Full Text] [PDF]

				M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text]

				K. B.S. Pasumarthi and L. J. Field Cardiomyocyte Cell Cycle Regulation Circ. Res., May 31, 2002; 90(10): 1044 - 1054. [Abstract] [Full Text] [PDF]

				L. A. Kirshenbaum Death-Defying Pathways Linking Cell Cycle and Apoptosis Circ. Res., May 25, 2001; 88(10): 978 - 980. [Full Text] [PDF]